Search

Your search keyword '"Gendzekhadze, Ketevan"' showing total 264 results

Search Constraints

Start Over You searched for: Author "Gendzekhadze, Ketevan" Remove constraint Author: "Gendzekhadze, Ketevan"
264 results on '"Gendzekhadze, Ketevan"'

Search Results

1. Seventy-five years of service: an overview of the College of American Pathologists proficiency testing program in histocompatibility and identity testing.

2. Treatment of Allosensitized Patients Receiving Allogeneic Transplantation

3. HLA alleles and haplotypes observed in 263 US families

4. Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.

5. A new strategy for systematically classifying HLA alleles into serological specificities: Update and refinement.

8. HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation

9. Seventy-five years of service: an overview of the College of American Pathologists’ proficiency testing program in histocompatibility and identity testing

12. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop

13. CO3-4 Des variants génétiques KIR non exprimés à la surface des cellules NK représenteraient un facteur de risque de rechute après greffes de CSH haplo-identiques

15. Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia

16. Specificity of HLA monoclonal antibodies and their use to determine HLA expression on lymphocytes and peripheral blood stem cells.

18. Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation

19. Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study

20. CMV-MVA Triplex Vaccination of Stem Cell Donors to Enhance CMV Specific Immunity and Prevent CMV Viremia in Recipients after Stem Cell Transplant

21. Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis

22. Adoptive transfer of functional SARS‐COV ‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipients

27. Prediction of Graft-Versus-Host Disease in Recipients of Single Mismatched Unrelated Hematopoietic Cell Transplantation Donor Using a Highly Multiplexed Proteomic Assay, MHC-Pepseq

29. Contribution des marqueurs polymorphes KIR et HLA sur le répertoire des cellules Natural Killer et impact en greffes de cellules souches hématopoïétiques haplo-identiques

32. Centromeric KIR AA Individuals Harbor Particular KIR Alleles Conferring Beneficial NK Cell Features with Implications in Haplo-Identical Hematopoietic Stem Cell Transplantation

33. Cytokine gene polymorphisms are associated with response to blinatumomab in B‐cell acute lymphoblastic leukemia

34. European HIV-HCV co-infected individuals Short title: HLA-C and spontaneous clearance in HIV-HCV coinfection

38. Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution

39. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals

40. Genetic and Molecular Basis of Heterogeneous NK Cell Responses against Acute Leukemia

41. Desensitization Therapy for Patients with DSA Receiving Haploidentical (Haplo) Stem Cell Transplantation

43. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-Lymphoblastoid cell lines : report from the 17th International HLA and Immunogenetics Workshop

44. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-Lymphoblastoid cell lines: report from the 17th International HLA and Immunogenetics Workshop

45. Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop

50. Incidence and Risk Factors of CMV Reactivation after Haploidentical Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide - Possible Role of Donor KIR Genotypes

Catalog

Books, media, physical & digital resources